CARAMBA HOLDING GMBH
Caramba Holding GmbH manufactures and sells chemical products for cleaning, care, and maintenance applications.
CARAMBA HOLDING GMBH
Industry:
Health Care Manufacturing
Founded:
1903-01-01
Address:
Kรผnzelsau, Baden-Wurttemberg, Germany
Country:
Germany
Website Url:
http://www.caramba.eu
Total Employee:
1001+
Status:
Active
Contact:
(492)037-7860
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Apache Wordpress Plugins
Similar Organizations
Ciba Holding
Ciba Holding is manufactures and markets specialty chemicals that provide color, performance, and care for plastics.
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2011-12-30 | Barnes Distribution Europe | Barnes Distribution Europe acquired by Caramba Holding GmbH | N/A |
Official Site Inspections
http://www.caramba.eu Semrush global rank: 3.29 M Semrush visits lastest month: 4.95 K
- Host name: www612.your-server.de
- IP address: 162.55.254.209
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Caramba Holding GmbH"
Our company - Our mission - Caramba
Caramba โ The brand of the century for the future Caramba is a German success story and has been your reliable partner with innovative strength and chemical know-how for 115 years. Since the filing of the first patent in 1903, our long โฆSee details»
CARAMBA
The pioneering CARAMBA project has come to an end . On 30 th June 2023, the EU-funded project CARAMBA has come to an end, marking five years of challenges and successes in the โฆSee details»
The Team - CARAMBA
Role in CARAMBA. The Universitätsklinikum Würzburg was the coordinating institution in CARAMBA and responsible for the successful conduct of the phase I/IIa clinical trial with โฆSee details»
News - CARAMBA
On 30th June 2023, the EU-funded project CARAMBA is coming to an end, marking five years of challenges and successes in the mission to revolutionise multiple myeloma treatment and โฆSee details»
Brand of the century - Caramba
As early as 2004, Caramba was awarded the coveted โBrand of the Centuryโ seal of quality for the first time. Together with companies such as adidas, BMW, tesa or Tempo, Caramba thus โฆSee details»
Milestones in the history of Caramba
Caramba graphite oil becomes the bestseller in Germany, the country of the economic miracle. 1965 Caramba is the first German company to develop a complete car care range. Due to its โฆSee details»
CARAMBA: New Hope for Multiple Myeloma Patients - Presseportal
Jun 30, 2023 CARAMBA: the European pioneer for virus-free CAR-T cell immunotherapy against multiple myeloma On 30th June 2023, the EU-funded project CARAMBA is coming to โฆSee details»
CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells ...
The CARAMBA clinical trial (Phase-I/IIA; EudraCT: 2019-001264-30) investigates the feasibility, safety, and anti-myeloma efficacy of autologous SLAMF7 CAR-T cells. CARAMBA is the first โฆSee details»
CARAMBA: the European pioneer for virus-free CAR-T cell โฆ
The EU-funded CARAMBA project has started in 2018 and is supported with a funding of 6.1 Mio โฌ. Within CARAMBA, ten partners of six EU countries are closely collaborating, among those โฆSee details»
SLAMF7-CAR T cells prepared by Sleeping Beauty gene-transfer โฆ
Since project start in 2018, the CARAMBA consortium has made rapid progress in implementing the project and clinical trial. The manufacturing authorization for SLAMF7 CAR T was obtained โฆSee details»
Quality products for cleaning, maintenance and care | Caramba
New range of products for the technical trade. Caramba has expanded its range for the technical trade. Get to know the innovative high-performance chemicals for industrial and parts โฆSee details»
CAR-T cell therapy advances treatment for multiple myeloma
The EU-funded CARAMBA project is using the revolutionary CAR-T cell technology to tackle multiple myeloma, developing a useful and affordable treatment for it and other rare diseases. โฆSee details»
The pioneering CARAMBA project is coming to an end
On 30 th June 2023, the EU-funded project CARAMBA is coming to an end, marking five years of challenges and successes in the mission to revolutionise multiple myeloma treatment and โฆSee details»
CARAMBA - Myeloma Patients Europe
The Horizon 2020 CARAMBA project started in January 2018. The project consortium is researching an innovative immunotherapy for the treatment of multiple myeloma, known as โฆSee details»
CARAMBA: New Hope for Multiple Myeloma Patients - ARTTIC โฆ
On 30th June 2023, the EU-funded project CARAMBA is coming to an end, marking five years of challenges and successes in the mission to revolutionise multiple myeloma treatment and โฆSee details»
CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells ...
Apr 13, 2021 The CARAMBA clinical trial (Phase-I/IIA; EudraCT: 2019-001264-30) investigates the feasibility, safety, and anti-myeloma efficacy of autologous SLAMF7 CAR-T cells.See details»
Contact - Caramba
Contact Caramba โ Call us on +49 (0)800 22 72 622See details»
Press Release | CARAMBA
In CARAMBA, the safety and efficacy of SLAMF7-specific CAR T cells will be evaluated in a Phase I/II clinical trial in patients. The European Commission selected the project from more โฆSee details»
Caramba Company Profile 2024: Valuation, Investors, Acquisition
Www.caramba.eu. Ownership Status. Acquired/Merged. Financing Status. Corporate Backed or Acquired. Corporate Office. Wanheimer Strasse 334-336; 47055 Duisburg; Germany ...See details»
SLAMF7-CAR T cell treatment of Multiple Myeloma patients
CARAMBA was the first clinical trial to target the myeloma-specific protein SLAMF7. The project had a mission to better understand the role of CAR-T therapy in myeloma and to explore โฆSee details»